Menu
Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1
First line targeted therapies in breast cancer: focus on bevacizumab || FREE PAPER ||
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,404 | Dovepress* | 7,404+ | 1,970 | 9,374 | |
| Totals | 7,404 | 1,970 | 9,374 | ||
|
*Since 15 August 2007 +Since July 2016 |
|||||
View citations on Google Scholar